Syrebo Secures Tens of Millions in Pre-A Funding to Advance Intelligent Rehabilitation Robotics

VCBeat has learned that Shanghai Siyi Intelligent Technology Co., Ltd., an internationally leading rehabilitation robotics company, announced it has secured a Pre-A round financing of tens of millions of RMB, exclusively invested by Kinghand Capital. According to the company, this round of financing will primarily be used to accelerate the upgrade and expansion of its stroke rehabilitation product series, develop more highly intelligent medical and consumer-grade rehabilitation robots, provide comprehensive neurological rehabilitation solutions, and significantly improve rehabilitation efficiency.

Founded in 2017, SIYI INTELLIGENCE initially focused on exploring the stroke rehabilitation robotics market after securing millions in angel-stage funding. It has emerged as a pioneer in China in applying cutting-edge soft robotics technology to clinical rehabilitation. To date, the company has secured over 30 proprietary patents, more than 10 of which are invention patents. It has participated in multiple national-level scientific and technological projects and has been officially certified as a National High-Tech Enterprise. The R&D team at SIYI INTELLIGENCE is composed entirely of engineers with advanced expertise in frontier robotics research and extensive product development experience. Regarding the YiSheng, which has gained widespread acclaim among hospitals and patients both domestically and internationally,^®Based on the hand function rehabilitation robot of the brand (international brand: Syrebo),SIYI INTELLIGENCEFurther explore the application of brain-computer interface (BCI) technology by capturing electroencephalogram (EEG) signals to stimulate the patient's voluntary intention, facilitate active movement of the affected hand, activate cerebral motor circuits, and reshape the patient's neural pathways.

SIYI INTELLIGENCE's EasyWalk under development^®China’s first soft lower-limb exoskeleton integrates biomimetic structural design with artificial intelligence control algorithms. The AI algorithm adaptively delivers optimal assistive strategies tailored to the wearer’s specific needs. This design eliminates the bulkiness and discomfort associated with traditional devices, featuring a lightweight build that provides assistance without restricting the body’s natural degrees of freedom. In the future, it will serve as an essential daily living assistant for patients with stroke, spinal paralysis, arthritis, and Parkinson’s disease, as well as elderly individuals with mobility impairments.

YISHENG^®The Hand Function Rehabilitation Robot Series integrates soft robotics technology with neuroscience principles, providing patients with a comprehensive range of training modes across the full rehabilitation cycle, including passive intelligent flexion-extension, assistive training, bimanual mirror therapy, and interactive gaming. It assists in reducing muscle tone in the affected hand, alleviating edema and stiffness in the finger joints, facilitating neurological recovery following brain injuries, and accelerating the overall rehabilitation process. As an internationally leading hand function rehabilitation robot, it comprehensively covers all stages from the flaccid paralysis phase to the recovery phase. The system has secured multiple authoritative medical device certifications, including China NMPA, US FDA, and EU CE. It is currently deployed in over 2,000 hospitals and has established in-depth collaborations with several top-tier Grade 3A hospitals, such as Huashan Hospital. A replicable 2B2C business model in the rehabilitation sector has been successfully implemented, forming the Yisheng...^®The brand's moat.

Led by SIYI INTELLIGENCE, the intelligent integration of medical-standard, consumer-grade rehabilitation robots significantly addresses the shortage of rehabilitation therapists in China and drives the development of the rehabilitation industry. Designed for professional rehabilitation medicine, these consumer-grade assistive devices feature low cost, strong interactivity, and advanced intelligent capabilities.

According to statistics, there is nearly a 30-fold gap between China and developed countries in the ratio of practicing rehabilitation physicians to the population. The emergence of consumer-grade rehabilitation robots that meet medical standards can effectively bridge this gap. Traditional rehabilitation training typically relies on one-on-one therapist guidance, which is both time-consuming and labor-intensive.Some rehabilitation robots on the market also suffer from cumbersome operation, with the donning time even exceeding the actual training duration.

The consumer-grade rehabilitation robot explored and developed by SIYI INTELLIGENCE integrated the design philosophy of human factors engineering from the outset. By comprehensively applying disciplines such as computer science, anthropometry, physiology, psychology, and cognitive science, the designmachines and systems that are better suited to human physiological and psychological characteristics。Currently, rehabilitation therapists can simultaneously operate multiple Yisheng devices.® Hand Function Rehabilitation Robot, Simultaneous Rehabilitation Training for Multiple Patients, significantly enhanced therapists'of / 'sRehabilitation Efficiency。

SIYI INTELLIGENCE’s vision is not confined to the hospital sector. Building on its technological expertise from professional hospital-grade products, SIYI INTELLIGENCE has also developed specialized rehabilitation solutions for communities and households, aiming to establish a full-cycle rehabilitation ecosystem that seamlessly connects hospitals, communities, and homes. "This embodies a full-cycle rehabilitation philosophy. We are not simply providing a device, but rather creating a closed-loop service that covers the entire rehabilitation process," said founder Yin Ganggang. Within SIYI INTELLIGENCE’s home rehabilitation system, rehabilitation therapists remotely prescribe personalized rehabilitation protocols, enabling users to conduct training at home according to these prescriptions. Data from home rehabilitation sessions is directly transmitted to a cloud platform, allowing therapists to monitor progress in real time. Additionally, SIYI INTELLIGENCE utilizes AI-assisted rehabilitation to dynamically adjust treatment plans in real time based on the user’s current condition. In the event of emergencies or unexpected situations, the system can instantly connect users with expert rehabilitation specialists for immediate intervention.

As the government continuously accelerates the implementation of policies supporting medical rehabilitation and broader health and wellness care, SIYI INTELLIGENCE aims to bridge hospitals and homes by developing highly intelligent consumer-grade rehabilitation robots. This will enable a wide range of stroke patients to access full-cycle, scientifically guided rehabilitation training, truly realizing personalized, precision rehabilitation for all.

Kinghand Capital is a leading private equity institution specializing in the healthcare sector. It is dedicated to leveraging capital and industry resources to accelerate the growth of outstanding healthcare enterprises, delivering superior medical products and services to society and advancing human health. The firm currently manages 10 RMB-denominated funds and 2 USD-denominated funds, with a total actual investment scale exceeding RMB 2 billion. To date, it has invested in 64 high-quality projects. Between 2019 and 2020, eight of its portfolio companies were listed on the Hong Kong Stock Exchange (HKEX) and the STAR Market, including Sino Medical-Device Technology (688108.SH), Viva Biotech (01873.HK), Jinxin Fertility (01951.HK), and Labp Biotechnologies (688393.SH). As of the current date in 2021, BeKang Medical (2170.HK), a portfolio company of Kinghand Capital, has been listed on the HKEX. Additionally, three companies have passed the listing committee reviews of the STAR Market and ChiNext, while four companies have had their IPO applications accepted. It is projected that more than 10 portfolio companies of Kinghand Capital will be listed on major domestic and international stock exchanges in 2021 and 2022.